Literature DB >> 23396152

Assessment of adiponectin and its isoforms in Polish centenarians.

Wojciech Bik1, Agnieszka Baranowska-Bik, Ewa Wolinska-Witort, Malgorzata Kalisz, Katarzyna Broczek, Malgorzata Mossakowska, Boguslawa Baranowska.   

Abstract

BACKGROUND: The physiological mechanisms that promote longevity remain unclear. It has been suggested that insulin sensitivity is preserved in centenarians, whereas typical aging is accompanied by increasing insulin resistance. The oldest-old individuals display raised total adiponectin levels, despite the potential correlation between enhanced adiponectin and all-cause and cardiovascular mortality. AIM: To evaluate the level of adiponectin and its isoforms in sera of centenarians and to assess associations between adiponectin and metabolic parameters. PARTICIPANTS: A group of 58 Polish centenarians (50 women and 8 men, mean age 101±1.34 years) and 68 elderly persons (55 women and 13 men, mean age 70±5.69 years) as controls. MEASUREMENTS: Serum samples were analyzed to evaluate the following parameters: adiponectin array (total adiponectin, HWM-, MMW- and LMW-adiponectin; all by ELISA methods), insulin (by IRMA methods), glucose and lipid profiles. HOMA-IR was calculated. Clinical data were collected. Statistical analyses were performed.
RESULTS: The concentrations of all adiponectin isoforms were significantly higher in the oldest-old participants. In the centenarian group, total adiponectin positively correlated with age and HDL-cholesterol, and HMW-adiponectin was negatively associated with insulin and triglycerides. The long-lived participants had a lower incidence of hypertension, type 2 diabetes, overweight and obesity, with lower concentrations of serum glucose and insulin, and reduced HOMA-IR.
CONCLUSION: Our findings support the thesis that centenarians possess a different adiponectin isoform pattern and have a favorable metabolic phenotype in comparison with elderly individuals. However, additional work is necessary to understand the relevance of these findings to longevity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396152     DOI: 10.1016/j.exger.2013.01.015

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  6 in total

Review 1.  Genome maintenance and human longevity.

Authors:  Miook Cho; Yousin Suh
Journal:  Curr Opin Genet Dev       Date:  2014-08-28       Impact factor: 5.578

2.  A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.

Authors:  Fabian Sanchis-Gomar; Helios Pareja-Galeano; Alejandro Santos-Lozano; Nuria Garatachea; Carmen Fiuza-Luces; Letizia Venturini; Giovanni Ricevuti; Alejandro Lucia; Enzo Emanuele
Journal:  Age (Dordr)       Date:  2015-04-25

Review 3.  Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week.

Authors:  Luca Liberale; Lina Badimon; Fabrizio Montecucco; Thomas F Lüscher; Peter Libby; Giovanni G Camici
Journal:  J Am Coll Cardiol       Date:  2022-03-01       Impact factor: 24.094

4.  Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms.

Authors:  Ping Li; Li Yang; Cui-Li Ma; Bo Liu; Xin Zhang; Rui Ding; Li-qi Bi
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

5.  Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.

Authors:  Leon Fisher; Wichat Srikusalanukul; Alexander Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

6.  Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report.

Authors:  Hideaki Nakatsuji; Ken Kishida; Hironori Kobayashi; Tohru Nakagawa; Tohru Funahashi; Iichiro Shimomura
Journal:  Diabetol Metab Syndr       Date:  2013-03-27       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.